FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309172008> ?p ?o ?g. }

• W4309172008 endingPage "1693.e3" @default.
• W4309172008 startingPage "1682" @default.
• W4309172008 abstract "Targeted therapy improves outcomes in patients with advanced-stage non-small cell lung cancer (NSCLC) and in the adjuvant setting, but data on its use before surgery are limited. We sought to investigate the safety and feasibility of preoperative targeted therapy in patients with operable NSCLC.We retrospectively reviewed 51 patients with clinical stage I to III NSCLC who received targeted therapy, alone or in combination with chemotherapy, before surgical resection with curative intent, treated from 2004 to 2021. The primary outcome was the safety and feasibility of preoperative targeted therapy; secondary outcomes included objective response rate, major pathologic response (defined as ≤10% viable tumor) rate, recurrence-free survival (RFS), and overall survival.Of the 51 patients included, 46 had an activating epidermal growth factor receptor gene alteration and 5 had an anaplastic lymphoma kinase fusion. Overall, 37 of 46 evaluable patients experienced at least 1 adverse event before surgery; however, only 3 patients experienced a grade 3 or 4 event. The objective response rate was 38% (17/45) for all evaluable patients and 44% (14/32) for patients with clinical stage II or III disease. The major pathologic response rate was 20% (9/44); 2 patients had a complete pathologic response. Median RFS was 3.8 years (95% CI, 2.8 to not reached). Targeted therapy alone was associated with better RFS than combination therapy (P = .009) in patients with clinical stage II or III disease.Preoperative targeted therapy was well tolerated and associated with good outcomes, with or without induction chemotherapy. In addition, radiographic response and pathologic response were strongly correlated." @default.
• W4309172008 created "2022-11-24" @default.
• W4309172008 creator A5002665417 @default.
• W4309172008 creator A5003134109 @default.
• W4309172008 creator A5014837967 @default.
• W4309172008 creator A5015965768 @default.
• W4309172008 creator A5023667267 @default.
• W4309172008 creator A5027524518 @default.
• W4309172008 creator A5034626553 @default.
• W4309172008 creator A5039791495 @default.
• W4309172008 creator A5042115782 @default.
• W4309172008 creator A5048552055 @default.
• W4309172008 creator A5055597008 @default.
• W4309172008 creator A5060033755 @default.
• W4309172008 creator A5062258585 @default.
• W4309172008 creator A5069016387 @default.
• W4309172008 creator A5083690652 @default.
• W4309172008 creator A5089673695 @default.
• W4309172008 creator A5090385143 @default.
• W4309172008 date "2023-05-01" @default.
• W4309172008 modified "2023-10-01" @default.
• W4309172008 title "Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer" @default.
• W4309172008 cites W1158033259 @default.
• W4309172008 cites W1988160404 @default.
• W4309172008 cites W2019607817 @default.
• W4309172008 cites W2028688614 @default.
• W4309172008 cites W2054951030 @default.
• W4309172008 cites W2068854404 @default.
• W4309172008 cites W2082839927 @default.
• W4309172008 cites W2096998881 @default.
• W4309172008 cites W2104504726 @default.
• W4309172008 cites W2106275780 @default.
• W4309172008 cites W2110024551 @default.
• W4309172008 cites W2114238186 @default.
• W4309172008 cites W2120844381 @default.
• W4309172008 cites W2124967121 @default.
• W4309172008 cites W2132157071 @default.
• W4309172008 cites W2134291074 @default.
• W4309172008 cites W2152481222 @default.
• W4309172008 cites W2153169173 @default.
• W4309172008 cites W2160708645 @default.
• W4309172008 cites W2166084034 @default.
• W4309172008 cites W2182482244 @default.
• W4309172008 cites W223909586 @default.
• W4309172008 cites W2518488558 @default.
• W4309172008 cites W2770075378 @default.
• W4309172008 cites W2784623697 @default.
• W4309172008 cites W2803822844 @default.
• W4309172008 cites W2887416920 @default.
• W4309172008 cites W2888877308 @default.
• W4309172008 cites W2891240143 @default.
• W4309172008 cites W2892483359 @default.
• W4309172008 cites W2896324394 @default.
• W4309172008 cites W2899724008 @default.
• W4309172008 cites W2951872058 @default.
• W4309172008 cites W2971041600 @default.
• W4309172008 cites W2971849142 @default.
• W4309172008 cites W2987053327 @default.
• W4309172008 cites W2992931937 @default.
• W4309172008 cites W2998092658 @default.
• W4309172008 cites W3010652892 @default.
• W4309172008 cites W3010836487 @default.
• W4309172008 cites W3087210493 @default.
• W4309172008 cites W3089266118 @default.
• W4309172008 cites W3097083397 @default.
• W4309172008 cites W3111438285 @default.
• W4309172008 cites W3135558153 @default.
• W4309172008 cites W3150188568 @default.
• W4309172008 cites W3155666522 @default.
• W4309172008 cites W3157423185 @default.
• W4309172008 cites W3165282291 @default.
• W4309172008 cites W3184279932 @default.
• W4309172008 cites W4214723455 @default.
• W4309172008 cites W4226360102 @default.
• W4309172008 cites W4226382697 @default.
• W4309172008 doi "https://doi.org/10.1016/j.jtcvs.2022.10.056" @default.
• W4309172008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36528430" @default.
• W4309172008 hasPublicationYear "2023" @default.
• W4309172008 type Work @default.
• W4309172008 citedByCount "1" @default.
• W4309172008 countsByYear W43091720082023 @default.
• W4309172008 crossrefType "journal-article" @default.
• W4309172008 hasAuthorship W4309172008A5002665417 @default.
• W4309172008 hasAuthorship W4309172008A5003134109 @default.
• W4309172008 hasAuthorship W4309172008A5014837967 @default.
• W4309172008 hasAuthorship W4309172008A5015965768 @default.
• W4309172008 hasAuthorship W4309172008A5023667267 @default.
• W4309172008 hasAuthorship W4309172008A5027524518 @default.
• W4309172008 hasAuthorship W4309172008A5034626553 @default.
• W4309172008 hasAuthorship W4309172008A5039791495 @default.
• W4309172008 hasAuthorship W4309172008A5042115782 @default.
• W4309172008 hasAuthorship W4309172008A5048552055 @default.
• W4309172008 hasAuthorship W4309172008A5055597008 @default.
• W4309172008 hasAuthorship W4309172008A5060033755 @default.
• W4309172008 hasAuthorship W4309172008A5062258585 @default.
• W4309172008 hasAuthorship W4309172008A5069016387 @default.
• W4309172008 hasAuthorship W4309172008A5083690652 @default.
• W4309172008 hasAuthorship W4309172008A5089673695 @default.

• next